ASAP3 (Gene)

Synonyms:ACAP4, ASAP3, ArfGAP with SH3 domain, ankyrin repeat and PH domain 3, CENTB6, DDEFL1, ENTREZ:55616, HGNC:14987, MIM:616594, NM_001143778, NM_017707, NP_001137250, NP_060177, UPLC1, XM_011541755, XM_017001685, XM_017001686, XM_017001687, XM_017001688, XM_017001689, XP_011540057, XP_016857174, XP_016857175, XP_016857176, XP_016857177, XP_016857178
Omim:OMIM:616594
Id:ENSG00000088280
Hgnc:HGNC:14987
Entrez:55616
Description:ArfGAP with SH3 domain, ankyrin repeat and PH domain 3
This gene encodes a member of a subfamily of ADP-ribosylation factor(Arf) GTPase-activating proteins that contain additional ankyrin repeat and pleckstrin homology domains. The Arf GAP domain of this protein catalyzes the hydrolysis of GTP bound to Arf proteins. The encoded protein promotes cell differentiation and migration and has been implicated in cancer cell invasion. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2009]

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View ASAP3's neighborhood in the knowledge graph.

Playbook Workflow Builder
Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with ASAP3.

Gene Partnership Appyter
CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using ASAP3.

Gene and Drug Landing Page Aggregator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for ASAP3.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with ASAP3.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.